Koneksa Enrolls First Patient in LEARNS Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders By Koneksa HealthNews NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that the first patient was enrolled in the LEARNS study, an observational study to determine the measurement...Read More February 20, 2024
